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A U-shaped relationship between alcohol




Background: Cardiometabolic index (CMI) is a new index for discriminating diabetes. The purpose of this study
was to determine whether CMI is affected by habitual alcohol drinking.
Methods: The subjects were 21572 men (35-60 years) receiving annual health checkups. They were divided by
average daily ethanol consumption into non-, light (<22 g), moderate (≥22 and < 44 g), heavy (≥44 and < 66 g) and
very heavy (≥66 g) drinkers. Relationship between alcohol intake and CMI was investigated with adjustment for age
and histories of smoking and regular exercise.
Results: Log-transformed CMI was significantly lower in light, moderate and heavy drinkers than in nondrinkers and
was lowest in light drinkers, while there was no significant difference in log-transformed CMI of nondrinkers and
very heavy drinkers. Odds ratio vs. nondrinkers for high CMI was significantly lower than the reference level of 1.00
in light, moderate and heavy drinkers and was lowest in light drinkers but was not significantly different from the
reference level in very heavy drinkers. Odds ratio of subjects with vs. those without high CMI for hyperglycemia was
significantly higher than the reference level in all of the alcohol groups and was significantly lower in moderate
drinkers but was not significantly different in the other drinker groups when compared with the nondrinker group.
Conclusion: There is a U-shaped relationship between alcohol consumption and CMI, and moderate drinking but
not excessive drinking attenuates the association between CMI and hyperglycemia.
Keywords: Alcohol, Cardiometabolic index, Diabetes mellitus Dyslipidemia, Obesity
Background
The incidence of cardiovascular disease has been re-
ported to be lower in light-to-moderate drinkers than in
abstainers [1, 2]. A major cause of this risk reduction is
HDL cholesterol-elevating action of alcohol [3, 4]. Sup-
pression of insulin resistance [5] and attenuation of
blood coagulability through inhibiting platelet aggrega-
tion [6] and decreasing circulating coagulation factors
[7] are also thought to be involved in the alcohol-
induced reduction of cardiovascular risk. On the other
hand, alcohol drinking is a risk factor of hypertension
[8, 9], which is an important etiology of cardiovascular
disease [10]. In addition, excessive drinking is associated
with an increase of blood triglyceride level [11, 12], and
hypertriglyceridemia is a component of metabolic syn-
drome [13] and is thought to be a cardiovascular risk fac-
tor [14, 15]. Thus, alcohol has both beneficial and harmful
effects on the risk of cardiovascular disease, depending on
the amount of alcohol consumption.
We have recently proposed cardiometabolic index
(CMI) as a new lipid- and adiposity-related index that is
strongly associated with prevalence of diabetes [16].
CMI is calculated as the product of waist-to-height ratio
and triglycerides-to-HDL cholesterol ratio and has been
shown to be associated with progression of atheroscler-
osis in patients with peripheral arterial disease (PAD)
[17]. Diabetes is an important risk factor of PAD, and an
inverse association has been shown between light-to-
moderate alcohol consumption and the risk of PAD [18].
However, it is unknown whether and how CMI is af-
fected by alcohol drinking. Light-to-moderate drinking
Correspondence: wakabaya@hyo-med.ac.jp
Department of Environmental and Preventive Medicine, Hyogo College of
Medicine, Mukogawa-cho 1-1, Nishinomiya, Hyogo 663-8501, Japan
© 2016 Wakabayashi. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Wakabayashi Lipids in Health and Disease  (2016) 15:50 
DOI 10.1186/s12944-016-0217-4
has been shown to be inversely associated with insulin
resistance, and the incidence of diabetes has been re-
ported to be lower in light-to-moderate drinkers than in
nondrinkers [5, 19, 20]. Thus, it is also of interest to
know whether the association between CMI and diabetes
is modified by alcohol drinking.
The purpose of this concise study was therefore to de-
termine the relationship between alcohol drinking and
CMI in a large population of middle-aged Japanese men
and to compare the strength of the association between
CMI and hyperglycemia among subject groups with
different amounts of alcohol consumption.
Methods
Subjects
The subjects were Japanese men aged 35 - 60 years
(n = 21572) who had received periodic health checkup ex-
aminations at workplaces in Yamagata Prefecture in Japan.
This study was approved by the Ethics Committee of
Yamagata University School of Medicine (No. 112 from
April 2005 to March 2006, approved on March 13, 2006).
Histories of alcohol consumption, cigarette smoking,
regular exercise (almost every day with exercise for
30 min or longer per day) and illness were surveyed by
questionnaires. Those who had been receiving drug ther-
apy for dyslipidemia (4.7 %) were excluded from the sub-
jects of this study. The subjects were divided into four
groups by average cigarette consumption (nonsmokers;
light smokers, < 20 cigarettes per day; heavy smokers, ≥ 20
and < 40 cigarettes per day; very heavy smokers, ≥ 40 ciga-
rettes per day).
Evaluation of alcohol consumption
Average alcohol consumption of each subject per week
was reported on questionnaires. Frequency of habitual
alcohol drinking was asked in the questionnaire as “How
frequently do you drink alcohol?”. Frequency of weekly
alcohol drinking was categorized as “every day” (regular
drinkers), “sometimes” (occasional drinkers) and “never”
(nondrinkers). Only regular drinkers who answered
“every day” were used as drinkers for analysis in this
study, since it was difficult to know the correct average
alcohol consumption of occasional drinkers who an-
swered “sometimes”. Occasional drinkers were thus ex-
cluded from subjects for analysis, and regular drinkers
were compared with nondrinkers in this study. Usual
weekly alcohol consumption was recorded in terms of
the equivalent number of “go”, a traditional Japanese
unit of amount of sake (rice wine). The amounts of
other alcoholic beverages, including beer, wine, whisky
and shochu (traditional Japanese distilled spirit), were
converted and expressed as units of “go”. One “go” con-
tains about 22 g of ethanol, and this amount was used to
separate moderate-to-heavy drinkers from light drinkers
since it is generally accepted that alcohol intake should
be reduced to less than 20 – 30 g ethanol per day from
the viewpoint of prevention of hypertension [21, 22].
Average daily alcohol intake (grams of ethanol per day)
was then calculated. The subjects were divided into five
groups according to ethanol consumption per day (non-
drinkers; light drinkers: < 22 g of ethanol per day; mod-
erate drinkers: ≥ 22 and < 44 g of ethanol per day; heavy
drinkers, ≥ 44 and < 66 g of ethanol per day; very heavy
drinkers: ≥ 66 g ethanol per day).
Measurements
Waist circumference was measured at the navel level ac-
cording to the recommendation of the definition of the
Japanese Committee for the Diagnostic Criteria of
Metabolic Syndrome [23]. Fasted blood was sampled
from each subject, and serum triglycerides and HDL
cholesterol were measured by enzymatic methods using
commercial kits, pureauto S TG-N and cholestest N-HDL
(Sekisui Medical Co., Ltd, Tokyo, Japan), respectively.
CMI was calculated as the product of waist-to-height ratio
and triglycerides-to-HDL cholesterol ratio, and high CMI
was defined as CMI ≥ 1.625, which has been reported to
discriminate hyperglycemia best in men [16]. Blood
hemoglobin A1c, which reflects glucose tolerance status
more correctly than does blood glucose, was used for
evaluation of hyperglycemia. Hemoglobin A1c was deter-
mined by the latex cohesion method using a commercial
kit (Determiner HbA1c, Kyowa Medex, Tokyo, Japan).
Coefficients of variation for reproducibility of each meas-
urement were ≤ 3 % for triglycerides and ≤ 5 % for HDL
cholesterol and hemoglobin A1c. Hemoglobin A1c values
were calibrated by using a formula proposed by the Japan
Diabetes Society (JDS) as hemoglobin A1c (National
Glycohemoglobin Standardization Program) (%) = 1.02 x
hemoglobin A1c (JDS) (%) + 0.25 % [24]. Hyperglycemia
including diabetes and prediabetes was defined as he-
moglobin A1c ≥ 5.7 % according to the criteria of the
American Diabetes Association [25]. Subjects receiving
drug therapy for diabetes were included in the hypergly-
cemia group.
Statistical analysis
Statistical analyses were performed using a computer
software program (SPSS version 16.0 J for Windows,
Chicago IL, USA). Mean levels of each quantitative vari-
able were compared using analysis of variance (ANOVA)
followed by Scheffé’s F-test in univariate analysis and
analysis of covariance (ANCOVA) followed by Student’s
t-test after Bonferroni correction in multivariate analysis.
Since triglycerides and CMI did not show a normal dis-
tribution, they were compared non-parametrically by
using the Kruskal-Wallis test followed by the Steel-
Dwass test in univariate analysis or were used after
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logarithmic transformation in ANCOVA. Comparison of
percentages of each categorical variable between groups
was performed using the chi-square test for independ-
ence. In logistic regression analysis, odds ratios for high
CMI or hyperglycemia were estimated. Age and histories
of smoking and habitual exercise were used as other ex-
planatory variables in multivariate analyses. In multivari-
ate analyses, smoking and exercise were defined
categorically as history of smoking in 4 levels (non, light,
heavy and very heavy smokers) and history of habitual
exercise in 2 levels (with and without history), res-
pectively. Age was used as a quantitative explanatory
variable. Crude odds ratios were compared between
different alcohol groups by using the Breslow-Day test.
Probability (p) values less than 0.05 were defined as
significant.
Results
Characteristics of the subjects
Table 1 shows the percentage, univariate mean, or me-
dian of each variable. Age was slightly but significantly
older in light, moderate and heavy drinkers than in non-
drinkers. The percentage of smokers was significantly
higher in light, moderate, heavy and very heavy drinkers
than in nondrinkers and tended to be higher with an in-
crease in alcohol intake. The percentage of subjects
doing exercise regularly was slightly but significantly
higher in moderate and very heavy drinkers than in
nondrinkers. The percentage of subjects receiving medica-
tion therapy for diabetes was significantly lower in light,
moderate, heavy and very heavy drinkers than in non-
drinkers. Height was slightly but significantly larger in
heavy and very heavy drinkers than in nondrinkers. Waist
circumference and WHtR were significantly smaller in
light and moderate drinkers than in nondrinkers, but
there was no significant difference between waist circum-
ference and WHtR in heavy and very heavy drinkers and
those in nondrinkers. Triglycerides were significantly
lower in light drinkers than in nondrinkers, were not sig-
nificantly different between moderate drinkers and non-
drinkers, and were significantly higher in heavy and very
heavy drinkers than in nondrinkers. HDL cholesterol was
significantly higher in light, moderate, heavy and very
heavy drinkers than in nondrinkers and tended to be
higher with an increase in alcohol intake. CMI and the
percentage of subjects with high levels of CMI were sig-
nificantly lower in light, moderate and heavy drinkers than
in nondrinkers but were not significantly different be-
tween very heavy drinkers and nondrinkers. Thus, there
was a U-shaped relationship between alcohol consump-
tion and CMI.
Comparison of CMI and each component of CMI among
the alcohol groups
Figure 1 shows means of log-transformed CMI and
its components, including WHtR, triglycerides (log-
Table 1 Characteristics of subjects
Overall subjects Drinker group
Non Light Moderate Heavy Very heavy
Number 21572 6430 2524 7741 4191 686
Age (years) 48.3 ± 7.5 47.0 ± 7.7 47.9 ± 7.6** 48.8 ± 7.4** 49.4 ± 7.2** 47.6 ± 7.3
Smokers (%) 61.0 55.3 58.8** 63.0** 65.7** 70.1**
Habitual exercise (%) 9.9 9.0 10.1 10.2* 10.1 12.4**
Therapy for diabetes (%) 2.7 3.7 2.6** 2.1** 2.5** 1.2**
Height (cm) 169.3 ± 6.2 169.1 ± 6.4 169.3 ± 6.1 169. 3 ± 6.0 169. 5 ± 6.0* 170. 1 ± 6.2**
Waist circumference (cm) 83.3 ± 8.7 83.5 ± 10.0 82.5 ± 8.1** 83.1 ± 8.1* 83.6 ± 8.1 84.2 ± 8.7
Waist-to-height ratio 0.492 ± 0.051 0.494 ± 0.058 0.487 ± 0.048** 0.491 ± 0.047** 0.493 ± 0.047 0.495 ± 0.049
Triglycerides (mg/dl) 118 (78, 185) 116 (79, 178) 109 (73, 164)** 118 (77, 184) 130 (80, 208)** 144 (88, 236)**
HDL cholesterol (mg/dl) 57.5 ± 15.4 50.8 ± 12.6 57.5 ± 14.2** 60.1 ± 15.6** 61.9 ± 16.0** 63.2 ± 16.6**
CMI 1.05 (0.59, 1.89) 1.16 (0.67, 2.07) 0.95 (0.55, 1.65)** 0.99 (0.56, 1.76)** 1.06 (0.57, 2.01)** 1.15 (0.64, 2.18)
1.60 ± 1.98 1.66 ± 1.65 1.38 ± 1.54 1.52 ± 1.91 1.77 ± 2.68 1.80 ± 1.98
High CMI (%) 30.7 34.3 25.8** 28.0** 32.1* 35.7
Hemoglobin A1c (%) 5.50 ± 0.72 5.61 ± 0.86 5.48 ± 0.69** 5.45 ± 0.61** 5.46 ± 0.71** 5.43 ± 0.67**
Hyperglycemia (%) 20.4 25.3 19.0** 18.4** 17.9** 17.3**
Shown are numbers of subjects and means with standard deviations, medians with 25 and 75 percentile values and percentages of each variable. The 25 and
75 percent values of triglycerides and cardiometabolic index (CMI) are shown in the parentheses following their median levels. Asterisks denote significant
differences from nondrinkers (*, p < 0.05; **, p < 0.01)
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transformed triglycerides) and HDL cholesterol, in the five
alcohol groups after adjustment for age and histories of
smoking and regular exercise. Log-transformed CMI was
significantly lower in light, moderate and heavy drinkers
than in nondrinkers but was not significantly different be-
tween very heavy drinkers and nondrinkers (Fig. 1a). Thus,
there was a U-shaped relationship between alcohol con-
sumption and log-transformed CMI. WHtR was signifi-
cantly lower in light and moderate drinkers than in
nondrinkers, but there was no significant difference be-
tween WHtRs in heavy and very heavy drinkers and that
in nondrinkers (Fig. 1b). Log-transformed CMI and WHtR
were lowest in light drinkers among the five alcohol
groups (Fig. 1a, b). Log-transformed triglycerides were sig-
nificantly lower in light drinkers than in nondrinkers, were
not significantly different between moderate drinkers and
nondrinkers, and were significantly higher in heavy and
very heavy drinkers than in nondrinkers (Fig. 1c). HDL
cholesterol was significantly higher in light, moderate,
heavy and very heavy drinkers than in nondrinkers and
tended to be higher with an increase in alcohol intake
(Fig. 1d).
Odds ratios vs. nondrinkers for high CMI in each
drinker group
Table 2 shows the results of logistic regression analysis
regarding the relationship between alcohol intake and
high CMI. Age and histories of smoking and regular ex-
ercise were adjusted in multivariate analysis. Both crude
and adjusted odds ratios vs. nondrinkers for high CMI
were significantly lower than the reference level of 1.00
in light, moderate and heavy drinkers and were lowest in
light drinkers among the four drinker groups. The crude
and adjusted odds ratios vs. nondrinkers for high CMI
were not significantly different from the reference level









































































































Fig. 1 Comparison of means of log-transformed CMI (a), waist-to-height ratio (b), log-transformed triglycerides (c) and HDL cholesterol (d) among
non-, light, moderate, heavy and very heavy drinkers. Shown are means with standard errors after adjustment for age and histories of smoking
and regular exercise. Asterisks denote significant differences from nondrinkers (**, p < 0.01)
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relationship between alcohol consumption and odds ra-
tio for high CMI.
Relationships of alcohol intake with hemoglobin A1c and
hyperglycemia
Hemoglobin A1c and the percentage of subjects with
hyperglycemia were significantly lower in light, moder-
ate, heavy and very heavy drinkers than in nondrinkers
(Table 1). In ANCOVA with adjustment for age and his-
tories of smoking, regular exercise and medication ther-
apy for diabetes, hemoglobin A1c was also significantly
lower (p < 0.01) in light, moderate, heavy and very heavy
drinkers than in nondrinkers (means with standard
errors: 5.60 ± 0.01 % [nondrinkers] vs. 5.49 ± 0.01 %
[light drinkers] vs. 5.45 ± 0.01 % [moderate drinkers] vs.
5.45 ± 0.01 % [heavy drinkers] vs. 5.46 ± 0.03 % [very
heavy drinkers]).
Odds ratios of subjects with vs. those without high CMI
for hyperglycemia in each drinker group
Table 3 shows the results of logistic regression analysis
regarding the relationship between alcohol intake and
hyperglycemia. Age and histories of smoking and regular
exercise were adjusted in multivariate analysis. Both
crude and adjusted odds ratios of subjects with vs. those
without high CMI for hyperglycemia were significantly
higher in non-, light, moderate, heavy and very heavy
drinkers. The crude odds ratio was significantly lower in
moderate drinkers than in nondrinkers but was not sig-
nificantly different between nondrinkers and light, heavy
or very heavy drinkers. Interaction of CMI and alcohol
intake for hyperglycemia was tested by using an inter-
action term consisting of CMI (high vs. not high CMI)
and alcohol (each drinker group vs. nondrinkers). Odds
ratio of the interaction term was significantly lower than
the reference level of 1.00 in moderate drinkers but was
not significantly different from the reference level in the
other drinker groups.
Comparison of the CMI-related variables in non- and very
heavy drinkers matched for height
Greater height in very heavy drinkers than in nondrinkers
(Table 1) is a possible confounder for the relationship be-
tween CMI and very heavy drinking (Fig. 1 and Table 2).
CMI was thus compared between nondrinkers and very
heavy drinkers matched for height. A nondrinker group
with the same number (n = 686) as that of very heavy
drinkers was prepared by randomly choosing subjects
from the database so that their heights showed a normal
distribution with the mean and standard deviation of
height being similar to those of very heavy drinkers (170.1
± 6.2 cm in Table 1). Using this population of nondrinkers,
CMI-related variables were compared between non-
drinkers and very heavy drinkers (Table 4). The median of
CMI and the mean of log-transformed CMI were not sig-
nificantly different in the nondrinker and very heavy
drinker groups. The percentage of subjects showing high
CMI was also not significantly different in the nondrinker
and very heavy drinker groups. Crude and adjusted odds
ratios vs. nondrinkers for high CMI were not significantly
different from the reference level of 1.00.
Discussion
This study is the first study showing the relationship be-
tween alcohol drinking and CMI, a recently proposed
index that is strongly associated with prevalence of
Table 2 Odds ratios for high cardiometabolic index (CMI) of each drinker group vs. the nondrinker group
Nondrinkers Light drinkers Moderate drinkers Heavy drinkers Very heavy drinkers
High CMI
Crude OR 1.00 0.67 (0.60–0.74)** 0.75 (0.70–0.80)** 0.91 (0.84–0.99)* 1.07 (0.90–1.26)
Adjusted OR 1.00 0.67 (0.60–0.74)** 0.73 (0.68–0.78)** 0.85 (0.78–0.93)** 0.95 (0.81–1.13)
Crude and adjusted odds ratios (ORs) with their 95 % confidence intervals in the parentheses are shown. Adjusted odds ratios for high CMI were estimated using
age and histories of smoking and habitual exercise as other explanatory variables. Asterisks denote significantly lower odds ratios compared with a reference level
of 1.00 (*, p < 0.05; **, p < 0.01)
Table 3 Odds ratios for hyperglycemia of subjects with vs. subjects without high cardiometabolic index (CMI)
Nondrinkers Light drinkers Moderate drinkers Heavy drinkers Very heavy drinkers Overall subjects
Hyperglycemia
Crude OR 2.31 (2.06-2.60)* 2.08 (1.69–2.57)* 1.83 (1.62–2.06)*,** 2.22 (1.89–2.61)* 2.38 (1.59–3.55)* 2.13 (1.99–2.28)*
Adjusted OR 2.31 (2.05-2.60) * 2.10 (1.69–2.62)* 1.89 (1.67–2.14)* 2.32 (1.97–2.73)* 2.42 (1.61–3.66)* 2.17 (2.02–2.33)*
OR of interaction term 1.00 0.89 (0.69–1.13) 0.80 (0.67–0.94)* 0.98 (0.80–1.20) 1.03 (0.68–1.58) —
Crude and adjusted odds ratios (ORs) with their 95 % confidence intervals in the parentheses are shown. Adjusted odds ratios for hyperglycemia were estimated
using age, smoking and habitual exercise as other explanatory variables. In analysis of overall subjects, alcohol drinking was also included in the explanatory
variables. Odds ratios of the interaction term consisting of alcohol intake (each drinker category vs. nondrinkers) and CMI (high vs. not high) were estimated by
using alcohol intake, CMI, the interaction term, age, smoking and habitual exercise as explanatory variables. Asterisks denote significantly higher or lower odds
ratios compared with a reference level of 1.00 (*, p < 0.01) and a significantly lower odds ratio compared with nondrinkers (**, p < 0.01)
Wakabayashi Lipids in Health and Disease  (2016) 15:50 Page 5 of 7
diabetes [16]. There was a U-shaped relationship be-
tween alcohol consumption and CMI (Fig. 1, Table 2).
These relationships were independent of smoking and
regular exercise in ANCOVA and multivariate logistic
regression analysis, although smoking and physical
activity are known to affect blood lipids and adiposity
[26, 27]. All CMI-related variables tested showed no
significant differences in nondrinkers and very heavy
drinkers matched for height. Thus, the difference in
height between nondrinkers and very heavy drinkers
(Table 1) did not confound the relationship between
CMI and very heavy drinking. CMI has been shown to
be related to progression of atherosclerosis in carotid ar-
tery and ischemia in leg artery of patients with periph-
eral arterial disease [17]. The finding of lower CMI in
light and moderate drinkers than in nondrinkers in the
present study agrees with the known lower risk of car-
diovascular disease in light-to-moderate drinkers than in
nondrinkers [1, 2]. Thus, modest alcohol drinking is in-
versely associated with prevalence of cardiovascular dis-
ease. On the other hand, no significant association was
found between CMI and very heavy drinking. Excessive
drinking is known to show adverse effects on cardiovas-
cular health [28]. In addition, alcohol is related not only
to cardiovascular disease but also to various other dis-
eases including cancer, and there is a possibility of alco-
hol abuse in drinkers. Therefore, needless to say, even
modest drinking should not be recommended.
The odds ratio of subjects with vs. those without high
CMI for hyperglycemia was significantly higher than the
reference level in non-, light, moderate, heavy and very
heavy drinkers. Thus, CMI was positively associated with
hyperglycemia in all of the alcohol groups. The odds
ratio for hyperglycemia was significantly lower only in
moderate drinkers than in nondrinkers, and the
interaction term of alcohol (each drinker group vs. non-
drinkers) and CMI (high vs. not high CMI) for
hyperglycemia was significantly lower than the reference
level only in moderate drinkers. These results imply that
the association between CMI and hyperglycemia was sig-
nificantly weaker in moderate drinkers than in non-
drinkers but was not significantly different in the other
drinker groups and nondrinkers. Thus, moderate drink-
ing is inversely associated with CMI, and the association
between cardiometabolic risk and diabetes is weaker in
moderate drinkers than in nondrinkers. The findings of
this study suggest that alcohol intake should be taken
into account when CMI is used as an index related to
the risk of atherosclerotic disease and diabetes.
CMI is calculated by WHtR, an adiposity index, and
triglycerides-to-HDL cholesterol ratio, a lipid index.
Lower WHtR and higher HDL cholesterol resulted in
lower CMI in light and moderate drinkers than in non-
drinkers, while comparable CMI levels in nondrinkers
and very heavy drinkers may be due to higher triglycer-
ides and higher HDL cholesterol in very heavy drinkers
than in nondrinkers. Lower triglycerides also contributed
to lower CMI in light drinkers than in nondrinkers. CMI
in heavy drinkers was significantly lower than that in
nondrinkers, and both HDL cholesterol and triglycerides
in heavy drinkers were higher than those in nondrinkers.
These results may imply that the influence of higher
HDL cholesterol on CMI is stronger than the influence
of higher triglycerides on CMI in heavy drinkers.
There are limitations of this study. Age and histories
of smoking and regular exercise were adjusted in multi-
variate analyses in this study. However, there are other
factors, e.g., diet, nutrition and socioeconomic factors in-
cluding education and occupation, possibly confounding
the relationship between alcohol consumption and the
components of CMI, such as adiposity and blood lipids,
and information on these possible confounders was not
available in this study. In addition, symptoms caused by
alcohol drinking, such as facial flushing and palpitation,
that are often found in Asians are mainly explained by
increase in blood acetoaldehyde level and are known to
be strongly influenced by polymorphism of genes of
alcohol-metabolizing enzymes, especially acetoaldehyde
dehydrogenase 2 (ALDH2) [29, 30]. Polymorphism of
the cholesteryl ester transfer protein (CETP) gene has
been shown to modify the relationship between
alcohol consumption and the risk of coronary artery
disease [31, 32]. However, information on the polymorph-
ism of these proteins was not included in the database
used in the present study. The subjects of this study were
Japanese men, and further studies are needed to deter-
mine the relationship between alcohol and CMI in women
and individuals of other races and/or ethnicities. This
study is cross-sectional in its design, and further prospect-
ive studies are also needed to clarify causality of the rela-
tionship between alcohol drinking and CMI.
Table 4 Comparison of cardiometabolic index (CMI)-related
variables between height-matched non- and very heavy
drinker groups
Nondrinkers Very heavy drinkers P value
Number 686 686 —
Height (cm) 170.05 ± 0.24 170.10 ± 0.24 0.88
CMI 1.15 (0.67, 2.15) 1.15 (0.64, 2.18) 0.69
Adjusted log(CMI) 0.095 ± 0.014 0.065 ± 0.014 0.15
High CMI (%) 32.7 33.5 0.77
OR for high CMI
Crude 1 1.01 (0.96-1.07) 0.73
Adjusted 1 0.98 (0.93-1.04) 0.53
Shown are numbers, means ± standard errors, medians with 25 and 75
percentile values indicated in parentheses, and odds ratios with 95 %
confidence intervals indicated in parentheses. Age and histories of smoking
and regular exercise were adjusted in multivariate analyses. OR odds ratio
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Conclusions
In conclusion, there was a U-shaped relationship be-
tween alcohol consumption and CMI, and the positive
association between CMI and hyperglycemia was weaker
in moderate drinkers but was not different in the other
drinker groups when compared with nondrinkers. Thus,
CMI and its relation to hyperglycemia are different in
drinkers and nondrinkers depending on the amount of
alcohol intake, and status of habitual drinking should be
taken into account when CMI is used as an index related
to the risk of atherosclerotic disease and diabetes.
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